The Speakers You Want to Hear

Announcing new additions to the Access! 2019 speaker lineup. Join 600+ attendees and 50+ exhibitors February 4-6 in New Orleans.

View Agenda
Prescription for Savings

Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.

Learn More
Generic Drugs are the Prescription for Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Patients Can See Their Savings

For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.

Learn More
Preserve Patient Access in Trade Agreements

The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Dec 10, 2018 | Rachel Schwartz

Andrew O’Connor Joins AAM as Manager, State Government Affairs

AAM Statement on Signing of USMCA by President

Nov 30, 2018 | Rachel Schwartz

AAM Statement on Signing of USMCA by President

AAM's Strategic Priorities for 2019

Nov 28, 2018 | Jewel Smith

You’re Invited! AAM Strategic Priorities Planning for the New Year

BCBS: It’s time to CREATE more choices & lower drug prices

Nov 28, 2018 | Chip Davis

BCBS: It’s time to CREATE more choices & lower drug prices

Generics and Biosimilars

Nov 27, 2018 | David Gaugh

Preliminary Recommendations for Addressing Drug Shortages

Video

Nov 19, 2018 | Erica Klinger

AAM CEO Chip Davis: Midterm Elections Will Impact Your Business